Thyroid Cancer Trial, Recruiting NCT05599139 Sponsor: University Medical Center Groningen Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT05599139
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man or woman aged 18 or older who has been diagnosed with differentiated thyroid cancer (a type of thyroid cancer)
  • You are required to follow a low-iodine diet before your radioactive iodine treatment, as part of standard thyroid cancer care in the Netherlands
  • You are well enough to follow the steps and requirements of the study
  • You are able to read and understand Dutch

Who may not be able to join:

  • You are under 18 years old
  • You are taking a heart medication called amiodarone
  • You have received an iodine-containing contrast dye (used in certain medical scans) within the last 3 months
  • You are currently pregnant
  • You are being prepared for radioactive iodine treatment using a man-made hormone injection called rhTSH (confirm with trial site)
  • You have significant kidney problems, specifically a kidney function measurement (eGFR) below 30 ml/min/1.73m² (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wouter Zandee, Dr., University Medical Center Groningen

Phone: +31503613731

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 February 2023
Est. completion
30 March 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Iodine uptake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov